Product NDC: | 64455-730 |
Proprietary Name: | WELLBUTRIN |
Non Proprietary Name: | bupropion hydrochloride |
Active Ingredient(s): | 150 mg/1 & nbsp; bupropion hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64455-730 |
Labeler Name: | BTA Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021515 |
Marketing Category: | NDA |
Start Marketing Date: | 20091223 |
Package NDC: | 64455-730-07 |
Package Description: | 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (64455-730-07) |
NDC Code | 64455-730-07 |
Proprietary Name | WELLBUTRIN |
Package Description | 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (64455-730-07) |
Product NDC | 64455-730 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | bupropion hydrochloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20091223 |
Marketing Category Name | NDA |
Labeler Name | BTA Pharmaceuticals |
Substance Name | BUPROPION HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |